marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Atara Biotherapeutics Cash Flow 2011-2024 | ATRA
Annual Cash Flow Atara Biotherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-193 M | -270 M | -221 M | -181 M | -236 M | -180 M | -87.5 M | -60 M | - | - | - | - | - |
Depreciation & Amortization |
4.83 M | 5.65 M | 9.34 M | 8.33 M | 7.07 M | 3.73 M | 956 K | 383 K | 48 K | 6 K | 4 K | - | - |
Accounts Payables |
3.68 M | 6.87 M | 17.4 M | 7.12 M | 7.96 M | 3.72 M | 14.7 M | 2.78 M | 1.44 M | 440 K | - | - | - |
Accounts Receivables |
34.1 M | 40.2 M | 986 K | 1.25 M | - | - | - | - | - | - | - | - | - |
Total Inventories |
9.71 M | 1.59 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Atara Biotherapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -29.6 M | - | - | - | -38.4 M | - | -214 M | -148 M | -84.5 M | - | -186 M | -127 M | -65.7 M | - | -177 M | -124 M | -67 M | - | -177 M | -125 M | -70.2 M | - | -122 M | -74.3 M | -34.8 M | - | -62.6 M | -42.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
600 K | 700 K | 1.39 M | - | 900 K | 900 K | 1.21 M | - | 1.1 M | 1.4 M | 1.59 M | - | 2.3 M | 2.3 M | 2.22 M | - | 2.2 M | 2.1 M | 1.95 M | - | 1.8 M | 1.8 M | 1.65 M | - | 1.2 M | 700 K | 333 K | - | 300 K | 200 K | 206 K | - | 100 K | 100 K | 15 K | - | 21 K | 11 K | 6 K | - | 4 K | 2 K | 1 K | - | 3 K | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
2.15 M | 5.25 M | 2.85 M | 3.68 M | 6.51 M | 4.14 M | 5.07 M | 6.87 M | 11.3 M | 12.8 M | 11.9 M | 17.4 M | 16.5 M | 12.3 M | 17.4 M | 7.12 M | 7.12 M | 7.12 M | 7.12 M | 7.96 M | 7.96 M | 7.96 M | 7.96 M | 3.72 M | 3.72 M | 3.72 M | 3.72 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 2.78 M | 2.78 M | 2.78 M | 2.78 M | 1.44 M | 1.44 M | 1.44 M | 1.44 M | 440 K | 440 K | 440 K | 440 K | 606 K | 606 K | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
1.34 M | 2.42 M | 35.8 M | 34.1 M | 163 K | 507 K | 397 K | 40.2 M | 249 K | 637 K | 668 K | 986 K | 800 K | 700 K | 9.61 M | 1.25 M | 1.25 M | 1.25 M | 1.25 M | - | 900 K | 900 K | 900 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
14 M | 18.7 M | 16.1 M | 9.71 M | 6.59 M | 7.86 M | 5.34 M | 1.59 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency